International Journal of Epidemiology 2001;30:1314-1315
© International Epidemiological Association 2001
Perinatal epidemiology |
Commentary: Little evidence of effective prenatal treatment against congenital toxoplasmosisthe implications for testing in pregnancy
Section of Epidemiology, National Institute of Public Health, PO Box 4404 Nydalen, 0403 Oslo, Norway.
Testing for antibodies against Toxoplasma gondii in pregnancy is routinely offered in some countries. However, no randomized controlled trials of the effect of treatment have been performed, and the question of whether testing in pregnancy should be encouraged rests on evidence from observational studies. Two such studies are presented in this issue. The first investigated the effect of timing and type of treatment on the risk of vertical transmission.1 The authors hypothesize that the lack of effect in their study is explained by rapid transmission to the fetus after maternal infection,
The French Studies in Context
Implications for Testing in Pregnancy
Future Research
References